Aviral Vatsa
A
thread 1/5
two months old but exciting developments from #ASCO2023 : GRAIL, a California-based company, has shared promising results from an NHS trial of its Galleri blood test. This innovative test can detect over 50 types of cancer by identifying DNA fragments from tumor cells in the blood. #CancerResearch
03:48 PM - Aug 06, 2023
Avatar Avatar Avatar
0
4
3
Aviral Vatsa
A
thread 2/5
The Galleri test was evaluated in the Symplify study led by the University of Oxford, involving 5,461 people in England and Wales with suspected cancer. The test correctly identified 66% of the cancer cases, showing particular effectiveness in older patients and later-stage cancers. #HealthTech
2/5
03:48 PM - Aug 06, 2023
1
2
Aviral Vatsa
A
thread 3/5
Not only did the Galleri test detect cancer, but in 85% of the correctly identified cases, it was also able to determine where the cancer originated. This could be a game-changer in early diagnosis and treatment planning. #CancerDetection
3/5
03:49 PM - Aug 06, 2023
1
1
Aviral Vatsa
A
thread 4/5
While these results are promising, more research is needed. The test could potentially support GPs in clinical assessments, but its impact on patient outcomes needs further investigation.

#MedicalResearch
4/5
03:50 PM - Aug 06, 2023
1
0
Aviral Vatsa
A
thread 5/5
The NHS is also trialling the Galleri test in asymptomatic individuals to detect hidden cancers. We're eagerly awaiting these results, which could revolutionize early cancer detection. Will try to keep you updated on this ground breaking progress. #CancerPrevention

5/5
03:51 PM - Aug 06, 2023
0
1

 

{{ notificationModalContent }} {{ promptModalMessage }}